ABSTRACT: Background and Aims: Visceral artery aneurysms (VAA) are a rare disease entity. Our study was designed to evaluate the etiology, presentation outcomes at 1 month in a tertiary care center for visceral artery aneurysms. Methods: We performed retrospective analysis of data from 2017-2021 at a tertiary care centre in Western India of all the patients with aneurysms. Results: Fifty-seven aneurysms and 48 pseudoaneurysms in 74 patients were studied. The most commonly involved vessels were splenic artery (69.5%) & gastroduodenal artery (GDA) (17.1%). About 75.6% patients were symptomatic, 51.3% had gastrointestinal bleeding (GI bleeding) & 24.3% abdominal pain. The most common etiologies noted were - Chronic Pancreatitis (35.1%) & deco...
ObjectiveMinimally invasive methods (MIMs) are now available for the management of visceral artery a...
Introduction: Visceral artery aneurysms remain a rare condition. A rupture is the dangerous complica...
Hepatic artery aneurysm (HAA) is a rare disease (0.002%– 0.4%) but is a clinically important pheno...
Objectives: To evaluate the incidence, management, and outcome of visceral artery aneurysms (VAA) ov...
AbstractPurpose: Aneurysms of the visceral arteries are infrequently encountered. Many are found inc...
Background: The aim of this study was to analyze differences in rupture risk and etiology of visc...
Abstract Background Visceral artery aneurysms (VAA) are rare vascular lesions. Clinically silent VAA...
Background: A 36-year-old female patient with no relevant clinical history was referred to the gastr...
BACKGROUND: Visceral artery aneurysms (VAA) are rare and the literature regarding management strateg...
Abstract BACKGROUND: Splanchnic artery areurysm is a rare but clinically relevant disease, showing a...
Objective. Visceral artery aneurysms are rare vascular malformations and the literature lacks satisf...
Visceral artery aneurysms (VAA) have an incidence of 0.01-2% and are mainly diagnosed as an incident...
Objective: Visceral artery aneurysms (VAAs) represent a pathologic condition with high mortality rat...
Visceral artery aneurysms (VAAs) are a rare, but serious clinical entity as rupture confers a high r...
Aim. The purpose of this study was to review the outcomes of endovascular treatment and open repair ...
ObjectiveMinimally invasive methods (MIMs) are now available for the management of visceral artery a...
Introduction: Visceral artery aneurysms remain a rare condition. A rupture is the dangerous complica...
Hepatic artery aneurysm (HAA) is a rare disease (0.002%– 0.4%) but is a clinically important pheno...
Objectives: To evaluate the incidence, management, and outcome of visceral artery aneurysms (VAA) ov...
AbstractPurpose: Aneurysms of the visceral arteries are infrequently encountered. Many are found inc...
Background: The aim of this study was to analyze differences in rupture risk and etiology of visc...
Abstract Background Visceral artery aneurysms (VAA) are rare vascular lesions. Clinically silent VAA...
Background: A 36-year-old female patient with no relevant clinical history was referred to the gastr...
BACKGROUND: Visceral artery aneurysms (VAA) are rare and the literature regarding management strateg...
Abstract BACKGROUND: Splanchnic artery areurysm is a rare but clinically relevant disease, showing a...
Objective. Visceral artery aneurysms are rare vascular malformations and the literature lacks satisf...
Visceral artery aneurysms (VAA) have an incidence of 0.01-2% and are mainly diagnosed as an incident...
Objective: Visceral artery aneurysms (VAAs) represent a pathologic condition with high mortality rat...
Visceral artery aneurysms (VAAs) are a rare, but serious clinical entity as rupture confers a high r...
Aim. The purpose of this study was to review the outcomes of endovascular treatment and open repair ...
ObjectiveMinimally invasive methods (MIMs) are now available for the management of visceral artery a...
Introduction: Visceral artery aneurysms remain a rare condition. A rupture is the dangerous complica...
Hepatic artery aneurysm (HAA) is a rare disease (0.002%– 0.4%) but is a clinically important pheno...